مجله علوم پزشکی پارس

فراوانی میزان اطلاع، درمان و کنترل پرفشاری خون در افراد 30 سال به بالا: یک مطالعه مقطعی در جمعیت شهری

نویسندگان

1 دانشیار، مرکز تحقیقات مولفه های اجتماعی سلامت، دانشگاه علوم پزشکی جهرم، جهرم،ایران

2 استاد، مرکز تحقیقات بیماری های غیرواگیر، دانشگاه علوم پزشکی جهرم، جهرم، ایران

3 استادیار،بخش داخلی، دانشگاه علوم پزشکی جهرم، جهرم، ایران

چکیده

مقدمه: بیماری پرفشاری خون یکی از مشکلات مهم سلامت عمومی در جهان است که فقدان کنترل آن با عوارضی همچون سکته قلبی،  سکته مغزی و نارسائی کلیه همراه است. هدف از مطالعه حاضر تعیین فراوانی میزان اطلاع و کنترل و درمان بیماری در جهرم بود.
روش کار: این مطالعه مقطعی روی 891 نفر ایرانی با سن 30 سال به بالای شهر جهرم که به روش نمونه گیری چند مرحله ای انتخاب شده بودند، انجام شد. افراد دارای فشار خون سیستول و یا دیاستول مساوی و یا بیشتر از 140/90 میلی متر جیوه و یا مصرف کننده داروهای کاهنده فشاری خون در گروه پرفشاری خون قرار گرفتند. بیمارانی که تحت درمان دارویی بودند و فشار خون آنها کمتر از  140/90 میلی متر جیوه بود به عنوان کنترل شده در نظر گرفته شدند.
یافته ها: از 315 بیمار مبتلا به پرفشاری خون، 47.9 % از بیماری خود اطلاع داشتند و 39.4 % تحت درمان بودند و 16.2 % فشار خون کنترل شده داشتند. در 36.3 % از بیماران تحت درمان، فشار خون در وضعیت کنترل شده بود. در مدل تطبیق شده، ابتلا به دیابت قندی و سن بالاتر با مطلع بودن و همچنین سن بالاتر با درمان شدن ارتباط مثبت و معناداری داشت.  
 نتیجه گیری:  در جمعیت تحت بررسی میزان اطلاع از پرفشاری خون، تحت درمان بودن و کنترل بیماری از وضعیت مناسبی برخوردار نبود.

کلیدواژه‌ها

عنوان مقاله [English]

Frequency of Awareness, Treatment, and Control of Hypertension in Individuals Aged 30 years or older: A Cross-Sectional Study in Urban Population

نویسندگان [English]

  • Karamatollah Rahmanian 1
  • Mohammad Shojaei 2
  • Fateme Eftekhareian 3

1 Associate Professor, Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran

2 Professor, Research Center for Non Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran

3 Assisstant Professor, Internal Medicine Ward, Jahrom University of Medical Sciences, Jahrom, Iran

چکیده [English]

Introduction: Hypertension is an important public health complaint in world. Inadequate hypertensive control was
associated with complications as myocardial infarction, cerebral stroke and renal failure. The aim of study was to determine prevalence of awareness, treatment, and control of hypertension in Jahrom.
Materials and Methods: This cross sectional study was done on 891 Iranian subjects aged 3o years or older who was selected through multi stage sampling method. Eight hundred ninety one subjects referred and studied. Subjects
who had either systolic/diastolic blood pressure ≥ 140/90 mm Hg or taking blood pressure lowering medications was defined as hypertension. Hypertensive patients who were under treatment and their blood pressure were less than 140/90 mmHg were determined as controlled.
Results: Of the total 315 hypertensive patients, 47.9% were aware, 39.4% were under treatment, and 16.2% had controlled blood pressure. Blood pressure was controlled in 36.3% of treated hypertensive patients. In the adjusted model, diabetes mellitus and older age was associated with higher awareness, and also, older age positively was associated with treatment.
Conclusion:
In study population the prevalence of awareness, treatment, and control had not adequate state

کلیدواژه‌ها [English]

  • Awareness
  • Hypertension
  • Diabetes Mellitus
  • Age
1. Global Health Observatory (GHO) data: NCD mortality and morbidity. www.who.int/gho/ncd/mortality_morbidity/en/. [Accessed 20 September 2018] 2018. 2. Sepanlou SG, Newson RB, Poustchi H, Malekzadeh MM, Rezanejad Asl P, Etemadi A, et al. Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran. Archives of Iranian medicine. 2015;18(3):144-52. 3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The Lancet. 2005;365(9455):217-23. 4. Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet. 2019;394(10199):639-51. 5. Bikbov MM, Kazakbaeva GM, Zainullin RM, Salavatova VF, Gilmanshin TR, Yakupova DF, et al. Prevalence, Awareness, and Control of Arterial Hypertension in a Russian Population. The Ural Eye and Medical Study. Front Public Health. 2020;7:394-. 6. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control. Current Hypertension Reports. 2019;21(4):27. 7. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, Treatment and Control of Pre-hypertension and Hypertension Among Adults in Iran. Archives of Iranian Medicine. 2016;19(7):456-64. 8. Ebrahimi M, Heidari-Bakavoli AR, Mazidi M, Moohebati M, Azarpazhooh MR, Nematy M, et al. Prevalence of hypertension, pre-hypertension and undetected hypertension in Mashhad, Iran. Mediterranean Journal of Nutrition and Metabolism. 2016;9:213-23. 9. Kazemi T, Hajihosseini M, Mashreghimoghadam H, Azdaki N, Ziaee M. Prevalence and Determinants of Hypertension among Iranian Adults, Birjand, Iran. Int J Prev Med. 2017;8:36-. 10. Mukhopadhyay K, Mukherjee S, Barkandaj B, Chatterjee C. Association of different socio-economic factors with hypertension prevalence, awareness, treatment and control in India: a demographic analysis of NFHS-4. Int J Res Med Sci. 2019;7(3):815-21. 11. Gandomkar A, Poustchi H, Malekzadeh F, Malekzadeh MM, Moini M, Moghadami M, et al. Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study. Arch Iran Med. 2018;21(8):335-43. 12. Rahmanian K, Shojaie M. The prevalence of pre-hypertension and its association to established cardiovascular risk factors in south of Iran. BMC Research Notes. 2012;5:386. 13. The WHO fact sheets No 311: obesity and overweight. Geneva: world health organization. 2006. 14. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. 15. Nikparvar M, Farshidi H, Madani A, Ezatirad R, Azad M, Eghbal Eftekhaari T, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Hormozgan Province, Iran. Int Cardiovasc Res J. 2019;13(3):91-5. 16. Ghorbani Z, Shamshirgaran S-M, Ghaffari S, Sarbakhsh P, Najafipour F, Aminisani N. Hypertension prevalence, awareness, treatment and its correlates among people 35 years and older: Result from pilot phase of the Azar cohort study. J Edu Health Promot. 2018;7:45. 17. Veghari G, Sedaghat M, Maghsodlo S, Banihashem S, Moharloei P, Angizeh A, et al. Impact of literacy on the prevalence, awareness, treatment and control of hypertension in adults in Golestan Province (northern Iran). Caspian J Intern Med. 2013;4(1):580-4. 18. Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiol Health. 2018;40:e2018020-e. 19. Liew SJ, Lee JT, Tan CS, Koh CHG, Van Dam R, Müller-Riemenschneider F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: a cross-sectional study. BMJ Open. 2019;9(5):e025869. 20. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Hum Hypertens. 2002;16(5):305-12. 21. Yazdanpanah L, Shahbazian H, Shahbazian H, Latifi S-M. Prevalence, awareness and risk factors of hypertension in southwest of Iran. J Renal Inj Prev. 2015;4(2):51-6. 22. Zinat-Motlagh SF, Chaman R, Ghafari SR, Parisay Z, Golabi MR, Eslami AA, et al. Knowledge, Treatment, Control, and Risk Factors for Hypertension among Adults in Southern Iran. International Journal of Hypertension. 2015;2015:897070. 23. Ghaffari S, Pourafkari L, Tajlil A, Sahebihagh MH, Mohammadpoorasl A, Tabrizi JS, et al. The prevalence, awareness and control rate of hypertension among elderly in northwest of Iran. J Cardiovasc Thorac Res. 2016;8(4):176-82. 24. Ware LJ, Chidumwa G, Charlton K, Schutte AE, Kowal P. Predictors of hypertension awareness, treatment and control in South Africa: results from the WHO-SAGE population survey (Wave 2). Journal of Human Hypertension. 2019;33(2):157-66. 25. Li T, Song X, Wu J, Li Z, Li L, Yu Y, et al. Awareness of hypertension and related factors in northeastern China: a cross-sectional study. Journal of Human Hypertension. 2020;34(1):43-50. 26. Khader Y, Batieha A, Jaddou H, Rawashdeh SI, El-Khateeb M, Hyassat D, et al. Hypertension in Jordan: Prevalence, Awareness, Control, and Its Associated Factors. International Journal of Hypertension. 2019;2019:3210617. 27. Adler AJ, Prabhakaran D, Bovet P, Kazi DS, Mancia G, Mungal-Singh V, et al. Reducing cardiovascular mortality through prevention and management of raised blood pressure: a World Heart Federation road- map. Glob Heart. 2015 10(2):111-22. 28. Jafari Oori M, Mohammadi F, Norouzi-Tabrizi K, Fallahi-Khoshknab M, Ebadi A. Prevalence of medication adherence in patients with hypertension in Iran: A systematic review and meta-analysis of studies published in 2000-2018. ARYA Atheroscler. 2019;15(2):82-92.
مجله علوم پزشکی پارس
دوره 17، شماره 4 - شماره پیاپی 50
دی 1398
صفحه 39-46